Microsatellite Instability and Lynch Syndrome

Vilar E, Scaltriti M, Balmana J, Saura C, Guzman M, Arribas J, Baselga J, Tabernero J. Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines. Br J Cancer. 2008;99(10):1607-12. PMCID: PMC2584960.

Vilar E, Mukherjee B, Kuick R, Raskin L, Misek DE, Taylor JM, Giordano TJ, Hanash SM, Fearon ER, Rennert G, Gruber SB. Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway. Clin Cancer Res 2009;15(8):2829-39. PMCID: PMC3425357.

Vilar E, Gruber SB Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010 Mar;7(3):153-62. PMCID: PMC3427139.

Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V, et al. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite instable colorectal cancers. Cancer Res. Feb 8 (Epub ahead of print). PMCID: PMC3407272

Vilar E, Tabernero J. Molecular Dissection of Microsatellite Instable Colorectal Cancer. Cancer Discov 3(5):502-11, 5/2013. e-Pub 3/2013. PMCID: PMC3651752

Diaz-Padilla I, Romero N, Amir E, Matias-Guiu X, Vilar E, Muggia F, Garcia-Donas J. Mismatch repair status and clinical outcome in endometrial cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 88(1):154-67, 10/2013. e-Pub 4/2013.

Clinical Genetics

You YN, Vilar E. Classifying MMR Variants: Time for Revised Nomenclature in Lynch Syndrome. Clin Cancer Res 19(9):2280-2, 5/2013. e-Pub 3/2013

Bannon SA, Mork M, Vilar E, Peterson SK, Lu K, Lynch PM, Rodriguez-Bigas MA, You YN. Patient-reported disease knowledge and educational needs in Lynch syndrome: findings of an interactive multidisciplinary patient conference. Hered Cancer Clin Pract 12(1):1, 2014. e-Pub 2/2014

Borras E, Taggart MW, Lynch PM, Vilar E. Establishing a Diagnostic Road Map for MUTYH Associated Polyposis. Clin Cancer Res 20(5):1061-3, 3/2014. e-Pub 1/2014. PMC3996649.

Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ. Cancer Genet. 2014 Oct-Dec;207(10-12):495-502. doi: 10.1016/j.cancergen.2014.10.002. Epub 2014 Oct 13. PMID: 25432668

Molecular Biology of Colorectal Cancer

Dienstmann R, Vilar E, Tabernero J. Molecular predictors of response to chemotherapy in colorectal cancer. Cancer J 17(2):114-26, Mar-Apr, 3/2011.

Vilar E, Perez-Garcia J, Tabernero J. Pushing the envelope in the mTOR pathway: the second generation of inhibitors. Mol Cancer Ther 10(3):395-403, 2011, 3/2011. e-Pub 1/2011. PMCID: PMCPMC3413411.
Vilar E, Tabernero J, Gruber SB. Micromanaging the classification of colon cancer: the role of the microRNAome. Clin Cancer Res 17(23):7207-9, 2011, 12/2011. e-Pub 10/2011. PMCID: PMCPMC3422018.

Vilar E, Tabernero J. Cancer: Pinprick diagnostics. Nature 486(7404):482-3, 6/2012. e-Pub 6/2012.

Goldstein J, Tran B, Ensor J, Gibbs P, Wong HL, Wong SF, Vilar E, Tie J, Broaddus R, Kopetz S, Desai J, Overman MJ. Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H). Ann Oncol 25(5):1032-8, 5/2014. e-Pub 2/2014. PMCID: PMC4072907

Morris VK, San Lucas FA, Overman MJ, Eng C, Morelli MP, Jiang ZQ, Luthra R, Meric-Bernstam F, Maru D, Scheet P, Kopetz S, Vilar E. Clinicopathologic Characteristics and Gene Expression Analyses of Non-KRAS 12/13, RAS-Mutated Metastatic Colorectal Cancer. Ann Oncol pii(mdu252). e-Pub 7/2014

Association between KRAS mutation and lung metastasis in advanced colorectal cancer. Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ, Hoff PM, Vauthey JN, Vilar E, Maru D, Kopetz S. Br J Cancer. 2015 Feb 3;112(3):424-8. doi: 10.1038/bjc.2014.619. Epub 2014 Dec 23.

Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment. Morelli MP, Overman MJ, Dasari A, Kazmi SM, Mazard T, Vilar E, Morris VK, Lee MS, Herron D, Eng C, Morris J, Kee BK, Janku F, Deaton FL, Garrett C, Maru D, Diehl F, Angenendt P, Kopetz S. Ann Oncol. 2015 Apr;26(4):731-6. doi: 10.1093/annonc/mdv005. Epub 2015 Jan 26. PMID: 25628445

Systems Biology

Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes. San Lucas FA, Fowler J, Chang K, Kopetz S, Vilar E, Scheet P. Mol Cancer Ther. 2014 Dec;13(12):3230-40. doi: 10.1158/1535-7163.MCT-14-0260. Epub 2014 Oct 27. PMID: 25349306

Related Departments

Related Care Centers